Cargando…

Leukocyte Expression of Type 1 and Type 2 Purinergic Receptors and Pro-Inflammatory Cytokines during Total Sleep Deprivation and/or Sleep Extension in Healthy Subjects

The purinergic type P1 (adenosine A(1) and A(2A)) receptors and the type P2 (X7) receptor have been suggested to mediate physiological effects of adenosine and adenosine triphosphate on sleep. We aimed to determine gene expression of A(1)R (receptor), A(2A)R, and P2RX(7) in leukocytes of healthy sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Chennaoui, Mounir, Arnal, Pierrick J., Drogou, Catherine, Leger, Damien, Sauvet, Fabien, Gomez-Merino, Danielle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411417/
https://www.ncbi.nlm.nih.gov/pubmed/28512397
http://dx.doi.org/10.3389/fnins.2017.00240
_version_ 1783232827087650816
author Chennaoui, Mounir
Arnal, Pierrick J.
Drogou, Catherine
Leger, Damien
Sauvet, Fabien
Gomez-Merino, Danielle
author_facet Chennaoui, Mounir
Arnal, Pierrick J.
Drogou, Catherine
Leger, Damien
Sauvet, Fabien
Gomez-Merino, Danielle
author_sort Chennaoui, Mounir
collection PubMed
description The purinergic type P1 (adenosine A(1) and A(2A)) receptors and the type P2 (X7) receptor have been suggested to mediate physiological effects of adenosine and adenosine triphosphate on sleep. We aimed to determine gene expression of A(1)R (receptor), A(2A)R, and P2RX(7) in leukocytes of healthy subjects during total sleep deprivation followed by sleep recovery. Expression of the pro-inflammatory cytokines IL-1β and TNF-α were also determined as they have been characterized as sleep regulatory substances, via P2RX(7) activation. Blood sampling was performed on 14 young men (aged 31.9 ± 3.9) at baseline (B), after 24 h of sleep deprivation (24 h-SD), and after one night of sleep recovery (R). We compared gene expression levels after six nights of habitual (22.30–07.00) or extended (21.00–07.00) bedtimes. Using quantitative real-time PCR, the amount of mRNA for A(1)R, A(2A)R, P2RX(7), TNF-α, and IL-1β was analyzed. After 24 h-SD compared to B, whatever prior sleep condition, a significant increase of A(2A)R expression was observed that returned to basal level after sleep recovery [day main effect, F((2, 26)) = 10.8, p < 0.001]. In both sleep condition, a day main effect on P2RX(7) mRNA was observed [F((2, 26)) = 6.7, p = 0.005] with significant increases after R compared with 24 h-SD. TNF-α and IL-1β expressions were not significantly altered. Before 24 h-SD (baseline), the A(2A)R expression was negatively correlated with the latency of stage 3 sleep during the previous night, while that of the A(1)R positively. This was not observed after sleep recovery following 24 h-SD. This is the first study showing increased A(2A)R and not A(1) gene expression after 24 h-SD in leukocytes of healthy subjects, and this even if bedtime was initially increased by 1.5 h per night for six nights. In conclusion, prolonged wakefulness induced an up-regulation of the A2A receptor gene expression in leukocytes from healthy subjects. Significant correlations between baseline expression of A(1) and A(2A) receptors in peripheral cells and stage 3 sleep suggested their involvement in mediating the effects of adenosine on sleep.
format Online
Article
Text
id pubmed-5411417
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54114172017-05-16 Leukocyte Expression of Type 1 and Type 2 Purinergic Receptors and Pro-Inflammatory Cytokines during Total Sleep Deprivation and/or Sleep Extension in Healthy Subjects Chennaoui, Mounir Arnal, Pierrick J. Drogou, Catherine Leger, Damien Sauvet, Fabien Gomez-Merino, Danielle Front Neurosci Neuroscience The purinergic type P1 (adenosine A(1) and A(2A)) receptors and the type P2 (X7) receptor have been suggested to mediate physiological effects of adenosine and adenosine triphosphate on sleep. We aimed to determine gene expression of A(1)R (receptor), A(2A)R, and P2RX(7) in leukocytes of healthy subjects during total sleep deprivation followed by sleep recovery. Expression of the pro-inflammatory cytokines IL-1β and TNF-α were also determined as they have been characterized as sleep regulatory substances, via P2RX(7) activation. Blood sampling was performed on 14 young men (aged 31.9 ± 3.9) at baseline (B), after 24 h of sleep deprivation (24 h-SD), and after one night of sleep recovery (R). We compared gene expression levels after six nights of habitual (22.30–07.00) or extended (21.00–07.00) bedtimes. Using quantitative real-time PCR, the amount of mRNA for A(1)R, A(2A)R, P2RX(7), TNF-α, and IL-1β was analyzed. After 24 h-SD compared to B, whatever prior sleep condition, a significant increase of A(2A)R expression was observed that returned to basal level after sleep recovery [day main effect, F((2, 26)) = 10.8, p < 0.001]. In both sleep condition, a day main effect on P2RX(7) mRNA was observed [F((2, 26)) = 6.7, p = 0.005] with significant increases after R compared with 24 h-SD. TNF-α and IL-1β expressions were not significantly altered. Before 24 h-SD (baseline), the A(2A)R expression was negatively correlated with the latency of stage 3 sleep during the previous night, while that of the A(1)R positively. This was not observed after sleep recovery following 24 h-SD. This is the first study showing increased A(2A)R and not A(1) gene expression after 24 h-SD in leukocytes of healthy subjects, and this even if bedtime was initially increased by 1.5 h per night for six nights. In conclusion, prolonged wakefulness induced an up-regulation of the A2A receptor gene expression in leukocytes from healthy subjects. Significant correlations between baseline expression of A(1) and A(2A) receptors in peripheral cells and stage 3 sleep suggested their involvement in mediating the effects of adenosine on sleep. Frontiers Media S.A. 2017-05-02 /pmc/articles/PMC5411417/ /pubmed/28512397 http://dx.doi.org/10.3389/fnins.2017.00240 Text en Copyright © 2017 Chennaoui, Arnal, Drogou, Leger, Sauvet and Gomez-Merino. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Chennaoui, Mounir
Arnal, Pierrick J.
Drogou, Catherine
Leger, Damien
Sauvet, Fabien
Gomez-Merino, Danielle
Leukocyte Expression of Type 1 and Type 2 Purinergic Receptors and Pro-Inflammatory Cytokines during Total Sleep Deprivation and/or Sleep Extension in Healthy Subjects
title Leukocyte Expression of Type 1 and Type 2 Purinergic Receptors and Pro-Inflammatory Cytokines during Total Sleep Deprivation and/or Sleep Extension in Healthy Subjects
title_full Leukocyte Expression of Type 1 and Type 2 Purinergic Receptors and Pro-Inflammatory Cytokines during Total Sleep Deprivation and/or Sleep Extension in Healthy Subjects
title_fullStr Leukocyte Expression of Type 1 and Type 2 Purinergic Receptors and Pro-Inflammatory Cytokines during Total Sleep Deprivation and/or Sleep Extension in Healthy Subjects
title_full_unstemmed Leukocyte Expression of Type 1 and Type 2 Purinergic Receptors and Pro-Inflammatory Cytokines during Total Sleep Deprivation and/or Sleep Extension in Healthy Subjects
title_short Leukocyte Expression of Type 1 and Type 2 Purinergic Receptors and Pro-Inflammatory Cytokines during Total Sleep Deprivation and/or Sleep Extension in Healthy Subjects
title_sort leukocyte expression of type 1 and type 2 purinergic receptors and pro-inflammatory cytokines during total sleep deprivation and/or sleep extension in healthy subjects
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411417/
https://www.ncbi.nlm.nih.gov/pubmed/28512397
http://dx.doi.org/10.3389/fnins.2017.00240
work_keys_str_mv AT chennaouimounir leukocyteexpressionoftype1andtype2purinergicreceptorsandproinflammatorycytokinesduringtotalsleepdeprivationandorsleepextensioninhealthysubjects
AT arnalpierrickj leukocyteexpressionoftype1andtype2purinergicreceptorsandproinflammatorycytokinesduringtotalsleepdeprivationandorsleepextensioninhealthysubjects
AT drogoucatherine leukocyteexpressionoftype1andtype2purinergicreceptorsandproinflammatorycytokinesduringtotalsleepdeprivationandorsleepextensioninhealthysubjects
AT legerdamien leukocyteexpressionoftype1andtype2purinergicreceptorsandproinflammatorycytokinesduringtotalsleepdeprivationandorsleepextensioninhealthysubjects
AT sauvetfabien leukocyteexpressionoftype1andtype2purinergicreceptorsandproinflammatorycytokinesduringtotalsleepdeprivationandorsleepextensioninhealthysubjects
AT gomezmerinodanielle leukocyteexpressionoftype1andtype2purinergicreceptorsandproinflammatorycytokinesduringtotalsleepdeprivationandorsleepextensioninhealthysubjects